Search research articles
Contact Us
Filters
Showing results (91-100 of 190) with videos related to
Page
of 19
Sort By:
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement
|
January 1, 1994
Immunological evidence for co-expression of cluster-5 and cluster-5A small cell lung cancer antigen on a single molecule
H P Lehmann, E Weber, T Schenker, et al.
Journal of Interpersonal Violence
|
September 9, 2025
Is There Harm in Asking? Relative Distress and Cost-Benefit of Sexual Assault-Focused Research Participation Among College-Aged Women
Elsa K Mattson, Jenna M Bagley, Cailan Splaine, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Malignant mesothelioma: clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients
L Tammilehto, T Tuomi, M Tiainen, et al.
Acta Radiologica: Diagnosis
|
September 1, 1986
Computed tomography of pleural lesions with special reference to the mediastinal pleura
O Salonen, L Kivisaari, C G Standertskjöld-Nordenstam, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Natural interferon alfa as maintenance therapy for small cell lung cancer
K Mattson, A Niiranen, S Pyrhönen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1987
Radiation pneumonitis and fibrosis following split-course radiation therapy for lung cancer. A radiologic and physiologic study
K Mattson, L R Holsti, H Poppius, et al.
British Journal of Cancer
|
February 14, 1998
Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung
A M Björkqvist, L Tammilehto, S Nordling, et al.
British Journal of Cancer
|
November 1, 1996
High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines
S Ungar, A Van de Meeren, L Tammilehto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study
E F Smit, K Mattson, J von Pawel, et al.
Bulletin of the International Union Against Tuberculosis
|
June 1, 1979
[Immunological aspects of reactions caused by rifampicin (proceedings)]
E Stevens, F Bloemmen, J M Mbuyi, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 190) with videos related to
Sort By:
Page
of 19
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement
|
January 1, 1994
Immunological evidence for co-expression of cluster-5 and cluster-5A small cell lung cancer antigen on a single molecule
H P Lehmann, E Weber, T Schenker, et al.
Journal of Interpersonal Violence
|
September 9, 2025
Is There Harm in Asking? Relative Distress and Cost-Benefit of Sexual Assault-Focused Research Participation Among College-Aged Women
Elsa K Mattson, Jenna M Bagley, Cailan Splaine, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Malignant mesothelioma: clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients
L Tammilehto, T Tuomi, M Tiainen, et al.
Acta Radiologica: Diagnosis
|
September 1, 1986
Computed tomography of pleural lesions with special reference to the mediastinal pleura
O Salonen, L Kivisaari, C G Standertskjöld-Nordenstam, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Natural interferon alfa as maintenance therapy for small cell lung cancer
K Mattson, A Niiranen, S Pyrhönen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1987
Radiation pneumonitis and fibrosis following split-course radiation therapy for lung cancer. A radiologic and physiologic study
K Mattson, L R Holsti, H Poppius, et al.
British Journal of Cancer
|
February 14, 1998
Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung
A M Björkqvist, L Tammilehto, S Nordling, et al.
British Journal of Cancer
|
November 1, 1996
High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines
S Ungar, A Van de Meeren, L Tammilehto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study
E F Smit, K Mattson, J von Pawel, et al.
Bulletin of the International Union Against Tuberculosis
|
June 1, 1979
[Immunological aspects of reactions caused by rifampicin (proceedings)]
E Stevens, F Bloemmen, J M Mbuyi, et al.
Page
of 19